4D Molecular Therapeutics, Inc. (FDMT) › Net Income4D Molecular Therapeutics, Inc. (FDMT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2019: -$49.31M2020: -$56.69M2021: -$71.32M2022: -$107.49M2023: -$100.84M2024: -$160.87M2025: -$140.11M-$140.11M2019Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$140.11M+12.9%2024-$160.87M-59.5%2023-$100.84M+6.2%2022-$107.49M-50.7%2021-$71.32M-25.8%2020-$56.69M-15.0%2019-$49.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share